Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications

医学 布比卡因 麻醉 肋间神经 外科
作者
Erin M. Corsini,K. G. Mitchell,Nicolas Zhou,Mara B. Antonoff,Reza J. Mehran,Gabriel E. Mena,Ravi Rajaram,Jack A. Roth,Boris Sepesi,Stephen G. Swisher,Ara A. Vaporciyan,Garrett L. Walsh,David C. Rice,Wayne L. Hofstetter
出处
期刊:The Annals of Thoracic Surgery [Elsevier BV]
卷期号:112 (2): 423-429 被引量:12
标识
DOI:10.1016/j.athoracsur.2020.09.017
摘要

Background We have previously demonstrated that Enhanced Recovery After Surgery protocols are associated with a reduction in pulmonary complications. As a component of enhanced recovery pathways, intercostal nerve blocks with liposomal bupivacaine are increasingly utilized, but the extent to which this element may contribute to such outcomes has not been evaluated. Methods Patients undergoing lung resection for stage I to III non-small cell lung cancer at a single institution from 2006 to 2017 were examined for major postoperative pulmonary morbidity, defined as pneumonia, acute respiratory distress syndrome, respiratory arrest, reintubation, bronchoscopy, or need for discharge with oxygen. Pharmacy records were queried for administration of liposomal bupivacaine via posterior intercostal nerve block. Patients treated with and without liposomal bupivacaine were compared in a logistic regression to determine the impact on pulmonary morbidity. Results A total of 2865 patients were identified, including 860 (30%) who were treated with liposomal bupivacaine via posterior intercostal block. Pulmonary morbidity occurred in 455 (16%). Adoption of liposomal bupivacaine analgesia occurred over several years, beginning in 2012 to full adoption by 2017. Liposomal bupivacaine management was associated with a reduction in pulmonary complications, as compared with nonuse (odds ratio, 0.63; P = .006). Additional factors associated with the occurrence of pulmonary morbidity were age, body mass index, smoking, spirometry values, and operative blood loss. Conclusions As a component of an active enhanced recovery program, liposomal bupivacaine is associated with a reduction in major pulmonary complications, and utilization should be evaluated on a hospital-by-hospital basis. We have previously demonstrated that Enhanced Recovery After Surgery protocols are associated with a reduction in pulmonary complications. As a component of enhanced recovery pathways, intercostal nerve blocks with liposomal bupivacaine are increasingly utilized, but the extent to which this element may contribute to such outcomes has not been evaluated. Patients undergoing lung resection for stage I to III non-small cell lung cancer at a single institution from 2006 to 2017 were examined for major postoperative pulmonary morbidity, defined as pneumonia, acute respiratory distress syndrome, respiratory arrest, reintubation, bronchoscopy, or need for discharge with oxygen. Pharmacy records were queried for administration of liposomal bupivacaine via posterior intercostal nerve block. Patients treated with and without liposomal bupivacaine were compared in a logistic regression to determine the impact on pulmonary morbidity. A total of 2865 patients were identified, including 860 (30%) who were treated with liposomal bupivacaine via posterior intercostal block. Pulmonary morbidity occurred in 455 (16%). Adoption of liposomal bupivacaine analgesia occurred over several years, beginning in 2012 to full adoption by 2017. Liposomal bupivacaine management was associated with a reduction in pulmonary complications, as compared with nonuse (odds ratio, 0.63; P = .006). Additional factors associated with the occurrence of pulmonary morbidity were age, body mass index, smoking, spirometry values, and operative blood loss. As a component of an active enhanced recovery program, liposomal bupivacaine is associated with a reduction in major pulmonary complications, and utilization should be evaluated on a hospital-by-hospital basis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
和谐的映梦完成签到,获得积分10
刚刚
量子星尘发布了新的文献求助10
刚刚
lll完成签到,获得积分20
刚刚
刚刚
明亮凡梦完成签到,获得积分10
1秒前
Ohoooo完成签到,获得积分10
2秒前
2秒前
蓝景轩辕完成签到 ,获得积分10
2秒前
项听蓉完成签到,获得积分10
3秒前
hao完成签到,获得积分10
3秒前
不安的白昼完成签到 ,获得积分10
4秒前
不知道完成签到,获得积分10
6秒前
6秒前
chebo发布了新的文献求助10
7秒前
一一一应助滕皓轩采纳,获得10
7秒前
一一一应助滕皓轩采纳,获得10
7秒前
科研通AI2S应助滕皓轩采纳,获得10
7秒前
大个应助十曰采纳,获得10
8秒前
li完成签到 ,获得积分10
9秒前
尘埃之影完成签到,获得积分10
11秒前
陶醉的钢笔完成签到 ,获得积分10
12秒前
飞行的子弹完成签到,获得积分20
13秒前
泥花完成签到,获得积分10
13秒前
13秒前
mr_beard完成签到 ,获得积分10
14秒前
岑晓冰完成签到 ,获得积分10
16秒前
啦啦啦完成签到,获得积分10
16秒前
感动的小鸽子完成签到 ,获得积分10
17秒前
lxj完成签到 ,获得积分10
17秒前
无辜的蜗牛完成签到 ,获得积分10
17秒前
xiaojin完成签到,获得积分10
18秒前
程程完成签到,获得积分10
18秒前
duckspy发布了新的文献求助30
18秒前
18秒前
sunyanghu369发布了新的文献求助30
23秒前
hdc12138完成签到,获得积分10
24秒前
飞龙在天完成签到,获得积分0
24秒前
狄淇儿完成签到 ,获得积分10
24秒前
吨吨完成签到,获得积分10
25秒前
小芒果完成签到,获得积分0
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022